day 1 agenda
| Scientific Program | ||
| Day -1: July (07, 2025) | ||
| Meeting Hall - 1 | ||
| Registrations Open (08:30-09:10) | ||
| Opening Ceremony (09:10-09:30) | ||
| Moderator: Jennie R Lill, Genentech Inc., United States |
||
| Keynote Talks | ||
| Mohamed El-Far, Mansoura University, Egypt |
09:30-10:00 | Title: Photodynamic therapy of tumors by Lasers from our bench discovery to clinical applications: Future perspective of using it in combination with our novel naturally derived nanoformulations as advancement therapy of cancer |
| Thomas Boldicke, Helmholtz Centre for Infection Research, Germany |
10:00-10:30 | Title: The future of cancer immunotherapy with recombinant T-cells and recombinant antibodies |
| Hui Zhang & Hong Sun, University of Nevada, United States |
10:30-11:00 | Title: Regulation of Hematopoiesis by A Methylation-Phosphorylation Switch in PRC2/EZH2 |
| Group Photo & Refreshment Break (11:00-11:20) | ||
| Scientific Session I | ||
| Morning Session: SessionChairs Thomas Boldicke, Helmholtz Centre for Infection Research, Germany & Maria J Nieto, Northwell Health Cancer Institute, United States |
||
| Jennie R Lill, Genentech Inc., United States |
11:20-11:40 | Title: TEAD-targeting small molecules trigger a cofactor switch to modulate the Hippo pathway |
| Maria J Nieto, Northwell Health Cancer Institute, United States |
11:40-12:00 | Title: AL Amyloidosis: A review of the literature |
| James Boyt, University of South Carolina, United States |
12:00-12:20 | Title: Development of a liquid biopsy: evaluating aberrant glycosylation in secreted and membrane glycoproteins |
| Fotios Mpekris, University of Cyprus, Cyprus |
12:20-12:40 | Title: Combination of two approaches to modify the tumor microenvironment and enhance the effectiveness of nano-immunotherapy |
| Kyle Cowan, Children's Hospital of Eastern Ontario, Canada |
12:40-13:00 | Title: APOBEC2: Its role in the pannexin 1-mediated inhibition of rhabdomyosarcoma progression and potential as a novel therapeutic target |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Scientific Session II | ||
| Afternoon Session: SessionChairs: Kyle Cowan, Children's Hospital of Eastern Ontario, Canada & Anne-Catherine Prats, INSERM/ University of Toulouse, France |
||
| Anne-Catherine Prats, INSERM/ University of Toulouse, France |
14:00-14:20 | Title: Translational control of lymphangiogenic growth factor expression by long lncRNAs |
| Navid Madani, Dana-Farber Cancer Institute Harvard Medical School, United States |
14:20-14:40 | Title: Roadblocks to Cancer Care in the Occupied Palestinian Territories |
| Esin Sevgi Dogan, Manisa Celal Bayar University, Turkey |
14:40-15:00 | Title: Knowledge, attitudes, and beliefs regarding skin cancer among health sciences students in Turkey: A cross-sectional study |
| Seront Emmanuel, Cliniques universitaires Saint Luc, Belgium |
15:00-15:20 | Title: Evolving Strategies in the Management of Metastatic Renal Cell Carcinoma: A Practical Guide for Clinicians |
| Ting-Ting Ma, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, China |
15:20-15:40 | Title: Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6 |
| Xiaotian Chen, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, China |
15:40-16:00 | Title: The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer |
| Refreshment Break(16:00-16:10) | ||
| Valentin Lecomte, University of Mons, Belgium |
16:10-16:30 | Title: Exploration of the radiosensitising potential of functionalised iron oxide nanoparticles |
| Yuexi Guo, Affiliated Hospital of North Sichuan Medical College, China |
16:30-16:50 | Title: Correlation Between Fatty Pancreas Disease and Pancreatic Diseases, Perioperative Complications of Pancreatic Surgery |
| Tehreem Fatima, University of Connecticut, United States |
16:50-17:10 | Title: The Effects of Belinostat and Long-Term AsiDNA Treatment on Gene Expression in Glioblastoma |
| Pannel Discussions | ||
| Conference Hotel: Hotel NH Danube City Address: Wagramer Str. 21, 1220 Wien, Austria |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
day 2 agenda
| Scientific Program | ||
| Day -2: July (08, 2025) | ||
| Meeting Hall - 1 | ||
| Keynote Talks | ||
| Pier Paolo Claudio, University of Mississippi Medical Center, United States |
09:00-09:30 | Title: Functional precision medicine using cancer stem cells in the era of precision medicine |
| Jagadananda Ghosh, Henry Ford Health System, United States |
09:30-10:00 | Title: Mechanism of antiandrogenic therapy resistance in prostate cancer: novel role of Tribbles 2 driving neuroendocrine trans-differentiation |
| Fuad Fares, University of Haifa, Israel |
10:00-10:30 | Title: Development of New Strategies for the treatment of Cancer Using Natural Products |
| Refreshment Break (10:30-10:40) | ||
| Scientific Session III | ||
| Morning Session: SessionChairs Shunfu Hu, Southern Illinois University, United States & Matilde Esther LLeonart, Vall d´Hebron Research Institute, Spain |
||
| Xinjian Lin, Fujian Medical University, China |
10:40-11:00 | Title: The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis |
| Vimolmas Tansathitaya, College of Sports Science and Technology, Mahidol University, Thailand |
11:00-11:20 | Title: Exercise Alters Microbiome Markers in Colorectal Cancer and Other Diseases |
| Matilde Esther LLeonart, Vall d´Hebron Research Institute, Spain |
11:20-11:40 | Title: New compounds targeting head and neck squamous cell carcinoma |
| Shunfu Hu, Southern Illinois University, United States |
11:40-12:00 | Title: Examining the Impact of Socio-demographic and Macro-environmental Factors on Cancer Mortality Rates in 2020 in Illinois, USA |
| Roland Hennes, University Heidelberg, Germany |
12:00-12:20 | Title: Primary Open Versus Closed Implantation Strategy for Totally Implantable Venous Access Ports |
| Jelena Sulic, University of Mostar School of Medicine, Bosnia and Herzegovina |
12:20-12:40 | Title: Correlation of Cytokine Profiles with Prostate-Specific Antigen and Disease Grade in Prostate Cancer |
| Fangzhou Liu, Nanjing Medical University, China |
12:40-13:00 | Title: Transcription factor DDIT3 is a potential driver in pancreatic cancer |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Afternoon Session: SessionChairs: Bat Chen R. Lubin, Eastern R&D center, Israel & Derek Roger Wilke, Dalhousie University, Canada |
||
| Poster presentations (14:00-14:40) | ||
| Scientific Session IV | ||
| Victoria Pham, Genentech Inc., United States |
14:40-15:00 | Title: Discovering Entrectinib Resistance Mechanisms: A Longitudinal Phosphoproteomics and Chemicogenomics Approach |
| Bat Chen R. Lubin, Eastern R&D center, Israel |
15:00-15:20 | Title: Targeting EGFR using cyclic peptide for the treatment of EGFR overexpressed cancer |
| Shiwen Luo, The First Affiliated Hospital of Nanchang University, China |
15:20-15:40 | Title: LncRNA HOTTIP modulated by Hedgehog signaling drives colorectal cancer progression by promoting HUWE1-mediated ubiquitin-proteasome degradation of p53 |
| Derek Roger Wilke, Dalhousie University, Canada |
15:40-16:00 | Title: The impact of National Holidays and early recurrence on outcomes in patients with squamous cell carcinoma of Head and Neck when treated by surgery and postoperative radiotherapy |
| Refreshment Break (16:00-16:10) | ||
| Annapaola Montagner, University of Bologna - Mayo Clinic, Italy |
16:10-16:30 | Title: The Notch signaling pathway: a promising druggable target for cancer treatment in combination with ICIs |
| Gulcin Ertas, SBÜ Ankara Oncology Training and Researche Hospital, Turkey |
16:30-16:50 | Title: General features of metaplastic breast carcinoma and case of bilateral squamous cell MBC |
| Poster presentations (14:00-14:40) | ||
| Stephanie Langlois, Children's Hospital of Eastern Ontario, Canada |
WCCRT-I | Title: Targeting pannexin 1 to inhibit the malignant properties of human high-risk neuroblastoma: potential for drug repurposing |
| Nasreen Nakad, University of Haifa, Israel |
WCCRT-II | Title: The role of thyrostimulin and its subunits in cancer cell growth |
| Jianping Chen, The university of Hong Kong, Hong Kong |
WCCRT-III | Title: Efficacy of a medical food YH0618 in ameliorating chemotherapy-induced toxicity: a randomized clinical trial |
| Mario Seres, Centre of Biosciences SAS, Slovakia |
WCCRT-IV | Title: Effect of UV-C radiation on parental and multidrug-resistant sublines of murine leukemia cells L1210 |
| Nasrin Fares Amer, University of Haifa, Israel |
WCCRT-V | Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer |
| Jakub Krepop, Centre of Biosciences SAS, Slovakia |
WCCRT-VI | Title: The role of epoxygenase of the arachidonic acid from P450 cytochrome family in proliferation of multidrug resistant leukemic cells |
| Lucia Pavlikova, Centre of Biosciences SAS, Slovakia |
WCCRT-VII | Title: TDo wolframin, P-glycoprotein, and GRP78/ BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity? |
| Pannel Discussions | ||
| Closing Ceremony | ||
| Conference Hotel: Hotel NH Danube City Address: Wagramer Str. 21, 1220 Wien, Austria |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
Virtual Agenda
| Scientific Program | ||
| Day -2: July (08, 2025) | ||
| Virtual Presentations (Time Zone: CET) | ||
| Lizhu Chen, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, China |
11:00-11:20 | Title: Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand–foot syndrome |
| Maocai Tang, Chongqing University Cancer Hospital, China |
11:20-11:40 | Title: The Comparative Study of Indocyanine Green and Carbon Nanoparticle Suspension Injection for Lymph Node Tracing in Laparoscopic Radical Gastrectomy for Gastric Cancer |
| Byung-Chul Lee, Genecast. co. ltd, South Korea |
11:40-12:00 | Title: Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology–Based EGFR Mutation Assay in NSCLC Patients |
| Eman Fares, Arab Academic College for Education in Israel - Haifa, Israel |
12:00-12:20 | Title: Inherited Cancer Risk: The Genetic Basis of Familial Cancer |
| Ewa Trybus, Jan Kochanowski University of Kielce, Poland |
12:20-12:40 | Title: Evaluation of anticancer acivity of new generation antihistamine fexofenadine against HeLa and A545 line |
| Wojciech Trybus, Jan Kochanowski University of Kielce, Poland |
12:40-13:00 | Title: Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells |
| Anna Nikitjuka, Latvian Institute of Organic Synthesis, Latvia |
13:00-13:20 | Title: TBA |
| Speaker slot available | 13:20-13:40 | Speaker slot available |
| Jekaterina Ivanova, Latvian Institute of Organic Synthesis, Latvia |
13:40-14:00 | Title: Inhibitors of selenoenzyme TrxR as anti-cancer agents – synthesis and biological evaluation |
| Aleksandrs Pustenko, Latvian Institute of Organic Synthesis, Latvia |
14:00-14:20 | Title: Thiazine 1,1-dioxide derivatives as potencial anticancer agents |
| Pinar Baydin, Ankara University, Turkey |
14:20-14:40 | Title: Role of Adhesion G Protein Coupled Receptors (aGPCRs) on Pericytes at Glioblastoma (GBM)- Pericyte Interaction |
| Speaker slot available | 14:40-15:00 | Speaker slot available |
| Liat Hamama, Tel Aviv University, Israel |
15:00-15:20 | Title: Dancing on the edge of the abyss Posttraumatic growth in men cancer survivors |
| Raimundo Fernandes de Araujo Júnior, Universidade Federal do Rio Grande do Norte, Brazil |
15:20-15:40 | Title: Extracellular Vesicles (EVs) from macrophages 1 as drugs carriers down-regulate the tumor progression and scape in murine colorectal cancer |
| Melinda Ildiko Mitranovici, ESHRE,ISSVD, Romania |
15:40-16:00 | Title: Cancer stemness: therapeutic and prognostic perspective in gynecology |
| Mariana Zuliani Theodoro De Lima, Mackenzie Presbyterian University/OncoAI, Brazil |
16:00-16:20 | Title: Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer |
| Anne Marinier, Université de Montréal, Canada |
16:20-16:40 | Title: Exploring ion chelators as a novel therapeutic modality in cancer |
| Chan Zhou, University of Massachusetts Chan Medical School, United States |
16:40-17:00 | Title: Flnc: Machine Learning Improves the Identification of Novel Long Noncoding RNAs from Stand-Alone RNA-Seq Data |
| Theodoros Karantanos, Johns Hopkins University, United States |
17:00-17:20 | Title: New insights into the biology and treatment of TP53 mutated myeloid neoplasms |
| Veda N Giri, Yale School of Medicine and Yale Cancer Center, United States |
17:20-17:40 | Title: Patient-Centered Approaches in the Evolving World of Germline Testing for Prostate Cancer |
| Richard G Pestell, Blumberg Institute, United States |
17:40-18:00 | Title: Immune Oncology Therapy for Cancer: CCR5 Inhibitors, Bench to Bedside |
| Amosy M'Koma, Vanderbilt University Medical Center, United States |
18:00-18:20 | Title: Inflammatory Bowel Disease – Associated Colorectal Cancer Posed by Exogenous Free Hemoglobin Alpha Chain, An Unknown By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis. |
| Christina M. Dieli-Conwright, Harvard Medical School, United States |
18:20-18:40 | Title: Getting to the heart of the matter: integration of exercise into cardio-oncology care |
| Speaker slot available | 18:40-19:00 | Speaker slot available |
| Closing Ceremony | ||
| Conference Hotel: Hotel NH Danube City Address: Wagramer Str. 21, 1220 Wien, Austria |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||